Richard P. Marshall

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

Pranabashis Haldar, Christopher E. Brightling, Beverley Hargadon et al. · New England Journal of Medicine · 2009 · 1.9K citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Veterinary Medicine, Immunology, Immunization +16

Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis

Philippe Gevaert, Nicholas Van Bruaene, Tom Cattaert et al. · Journal of Allergy and Clinical Immunology · 2011 · 624 citations · Full text

Medicine, Immunology, Pharmacology +16

Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial

Claus Bachert, Ana R. Sousa, Valerie Lund et al. · Journal of Allergy and Clinical Immunology · 2017 · 505 citations · Full text

Medicine, Otolaryngology, Surgery +11